Gene · 64798
Papers1,775
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 1,775
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Phosphorylation of OTUB1 promotes autophagy initiation under starvation. | Nat Commun | 2026 | 42736303 | PubTator, text mining | PubMed |
| Retraction: A Novel Therapeutic Induces DEPTOR Degradation in Multiple Myeloma Cells with Resulting Tumor Cytotoxicity. | Mol Cancer Ther | 2026 | 42548210 | PubTator, text mining | PubMed |
| Retraction: Cytotoxic Properties of a DEPTOR-mTOR Inhibitor in Multiple Myeloma Cells. | Cancer Res | 2026 | 42452978 | PubTator, text mining | PubMed |
| Screening Biomarkers Related to Circadian Rhythm of Gastric Cancer Through Bioinformatics. | Appl Biochem Biotechnol | 2026 | 42287537 | PubTator, text mining | PubMed |
| Computational investigation of biochanin a targeting DEPTOR in Alzheimer's disease with in vitro cellular validation of neuroprotective activity. | Sci Rep | 2026 | 41963454 | PubTator, text mining | PubMed |
| Overlapping genetic etiology of pediatric and adult germ cell tumors. | J Natl Cancer Inst | 2026 | 41941753 | PubTator, text mining | PubMed |
| Tear Biomarkers of Topical Sirolimus in Meibomian Gland Dysfunction: A Randomized Trial. | Clin Ophthalmol | 2026 | 41929713 | PubTator, text mining | PubMed |
| Time-Restricted Eating, Cardiometabolic Health in Obesity and The Optimal Length of the Eating Window. | Curr Nutr Rep | 2026 | 41801605 | PubTator, text mining | PubMed |
| Molecular mechanisms and therapeutic targeting implications of ER/mTOR signaling axis-driven tumor progression in aggressive meningiomas. | Transl Oncol | 2026 | 41794007 | PubTator, text mining | PubMed |
| Integrated multi-omics profiling to dissect the development of second primary lung cancer in laryngeal cancer: An observational study. | Medicine (Baltimore) | 2026 | 41790655 | PubTator, text mining | PubMed |
| Correction: Regulation of metabolic adaptation and leukemia progression by MUSASHI2-DEPTOR-KIF11 axis. | Leukemia | 2026 | 41787068 | PubTator, text mining | PubMed |
| Targeting cancer hallmarks using resveratrol: isolation, formulation, and mechanisms of action. | Front Nutr | 2026 | 41737343 | PubTator, text mining | PubMed |
| Otubain deubiquitinases: Multi-layered regulators of cell fate, development, and stress responses across kingdoms. | iScience | 2026 | 41550777 | PubTator, text mining | PubMed |
| Correspondence to "Regulation of metabolic adaptation and leukemia progression by MUSASHI2-DEPTOR-KIF11 axis". | Leukemia | 2026 | 41225181 | PubTator, text mining | PubMed |
| Mutant p53 binds and controls estrogen receptor activity to drive endocrine resistance in ovarian cancer. | Genes Dev | 2026 | 41193244 | PubTator, text mining | PubMed |
| NFIC activates DEPTOR and blocks mTOR signaling to inhibit glycolysis and immune escape in oral squamous cell carcinoma. | Arch Oral Biol | 2026 | 41176831 | PubTator, text mining | PubMed |
| CEBPB, C19MC, and Defective Autophagy Drive Novel Podosomal Belt to Macropinocytosis Transition, Lipid Accumulation, and HBV A-to-I RNA-editing. | Res Sq | 2025 | 41282072 | PubTator, text mining | PubMed |
| DEPTOR regulates nucleus pulposus cell senescence through the mTORC1/S6K1/ATG1 pathway to alleviate intervertebral disk degeneration. | Cell Death Discov | 2025 | 41249115 | PubTator, text mining | PubMed |
| Normalization of trophoblast mTOR signaling rescues impaired function in primary human trophoblast cells isolated from pregnancies complicated by fetal growth restriction. | Cell Death Discov | 2025 | 41203646 | PubTator, text mining | PubMed |
| Regulation of metabolic adaptation and leukemia progression by MUSASHI2-DEPTOR-KIF11 axis. | Leukemia | 2025 | 41034423 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/64798/papers